Decoy Therapeutics Partners with Quantori to Enhance AI-Driven Peptide Design via Google Cloud
Decoy Therapeutics and Quantori: A Groundbreaking Partnership
In a significant move for the biotechnology sector, Decoy Therapeutics has forged a strategic partnership with Quantori, focusing on advancing antiviral treatment through an innovative AI-driven peptide design and molecular simulation platform powered by Google Cloud. With funding assistance from Google Cloud, this collaboration is expected to revolutionize the speed and effectiveness of peptide discovery, enhancing Decoy's capabilities in designing multi-antivirals (D-MAVs™) that are engineered to combat various viral infections.
The Vision Behind the Partnership
Rick Pierce, CEO of Decoy Therapeutics, emphasized the importance of this collaboration, stating that it
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.